RIG-I-like receptors: Cytoplasmic sensors for non-self RNA

Immunological Reviews

Volumn 243, Issue 1, 2011, Pages 91-98

  Kato, Hiroki ^a   Takahasi, Kiyohiro ^a   Fujita, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Antiviral innate immunity; Non self RNA; RIG I like receptors; Type I interferon

Indexed keywords

5' TRIPHOSPHATE RNA; CYTOKINE; DOUBLE STRANDED RNA; HELICASE; I KAPPA B KINASE; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; LGP2 RECEPTOR; LYSINE; MDA 5 RECEPTOR; NONSELF RNA; POLYINOSINIC POLYCYTIDYLIC ACID; POLYURIDYLIC ACID; PROTEIN TYROSINE PHOSPHATASE SHP 1; RETINOIC ACID INDUCIBLE I LIKE RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; RETINOIC ACID RECEPTOR; RIBONUCLEASE; RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG; VIRUS RNA;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; CYTOPLASM; DENGUE VIRUS; ENCEPHALOMYOCARDITIS VIRUS; ENZYME ACTIVATION; EPSTEIN BARR VIRUS; HEPATITIS C VIRUS; INFLUENZA VIRUS A; INNATE IMMUNITY; JAPANESE ENCEPHALITIS VIRUS; MEASLES VIRUS; MENGO VIRUS; MITOCHONDRION; MURINE ENCEPHALOMYELITIS VIRUS; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS REGULATION; PROTEIN TRANSPORT; REOVIRUS; REVIEW; RNA CLEAVAGE; RNA VIRUS; SENDAI VIRUS; SIGNAL TRANSDUCTION; UBIQUITINATION; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, VIRAL; CYTOPLASM; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERFERON TYPE I; MOLECULAR STRUCTURE; RECEPTORS, PATTERN RECOGNITION; RECEPTORS, RETINOIC ACID; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 80052143412     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2011.01052.x     Document Type: Review

References (73)

1. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805-820.
2. Fujita T. A nonself RNA pattern: tri-p to panhandle. Immunity 2009;31:4-5.
3. Beutler B, et al. Genetic analysis of resistance to viral infection. Nat Rev Immunol 2007;7:753-766.
4. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732-738.
5. Heil F, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526-1529.
6. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004;303:1529-1531.
7. Hemmi H, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002;3:196-200.
8. Hemmi H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-745.
9. Yoneyama M, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004;5:730-737.
10. Yoneyama M, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005;175:2851-2858.
11. Takahasi K, et al. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 2008;29:428-440.
12. Kawai T, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005;6:981-988.
13. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005;19:727-740.
14. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005;122:669-682.
15. Meylan E, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005;437:1167-1172.
16. Kato H, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006;441:101-105.
17. Kato H, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005;23:19-28.
18. Gitlin L, et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad USA 2006;103:8459-8464.
19. McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, Colonna M. MDA-5 recognition of a murine norovirus. PLoS Pathog 2008;4:e1000108.
20. Roth-Cross JK, Bender SJ, Weiss SR. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J Virol 2008;82:9829-9838.
21. Foy E, et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci USA 2005;102:2986-2991.
22. Loo YM, et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008;82:335-345.
23. Fredericksen BL, Gale M Jr. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol 2006;80:2913-2923.
24. Shingai M, et al. Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus. J Immunol 2007;179:6123-6133.
25. Kato H, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008;205:1601-1610.
26. Satoh T, et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA 2010;107:1512-1517.
27. Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J 2006;25:4207-4214.
28. Rasmussen SB, et al. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene- like receptors, which synergize to induce type I interferon production. J Gen Virol 2009;90:74-78.
29. Grunberg-Manago M, Oritz PJ, Ochoa S. Enzymatic synthesis of nucleic acidlike polynucleotides. Science 1955;122:907-910.
30. Kim DH, Longo M, Han Y, Lundberg P, Cantin E, Rossi JJ. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 2004;22:321-325.
31. Hornung V, et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006;314:994-997.
32. Pichlmair A, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006;314:997-1001.
33. Pallansch MA, Kew OM, Palmenberg AC, Golini F, Wimmer E, Rueckert RR. Picornaviral VPg sequences are contained in the replicase precursor. J Virol 1980;35:414-419.
34. Habjan M, et al. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 2008;3:e2032.
35. Ishii KJ, et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 2006;7:40-48.
36. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009;10:1065-1072.
37. Chiu YH, MacMillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type i interferons through the RIG-I pathway. Cell 2009;138:576-591.
38. Nallagatla SR, Hwang J, Toroney R, Zheng X, Cameron CE, Bevilacqua PC. 5'-triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 2007;318:1455-1458.
39. Hausmann S, Marq JB, Tapparel C, Kolakofsky D, Garcin D. RIG-I and dsRNA-induced IFNbeta activation. PLoS ONE 2008;3:e3965.
40. Rehwinkel J, et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010;140:397-408.
41. Pichlmair A, et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 2009;83:10761-10769.
42. Malathi K, Dong B, Gale M Jr, Silverman RH. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007;448:816-819.
43. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008;454:523-527.
44. Cui S, et al. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell 2008;29:169-179.
45. Takahasi K, et al. Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors. J Biol Chem 2009;284:17465-17474.
46. Lu C, et al. The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain. Structure 2010;18:1032-1043.
47. Wang Y, et al. Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struct Mol Biol 2010;17:781-787.
48. Lu C, Ranjith-Kumar CT, Hao L, Kao CC, Li P. Crystal structure of RIG-I C-terminal domain bound to blunt-ended double-strand RNA without 5' triphosphate. Nucleic Acids Res 2011;39:1565-1575.
49. Li X, et al. The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA. J Biol Chem 2009;284:13881-13891.
50. Fitzgerald KA, et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003;4:491-496.
51. Hemmi H, et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 2004;199:1641-50.
52. Häcker H, et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006;439:204-207.
53. Sato M, et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000;13:539-548.
54. Honda K, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005;434:772-777.
55. Takahashi K, Kawai T, Kumar H, Sato S, Yonehara S, Akira S. Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J Immunol 2006;176:4520-4524.
56. An H, et al. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat Immunol 2008;9:542-550.
57. Diao F, et al. Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase. Proc Natl Acad Sci USA 2007;104:11706-11.
58. Moore CB, et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008;451:573-577.
59. Huang J, Liu T, Xu LG, Chen D, Zhai Z, Shu HB. SIKE is an IKKε/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways. EMBO J 2005;24:4018-4028.
60. Jounai N, et al. The Atg5-Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci USA 2007;104:14050-14055.
61. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008;455:674-678.
62. Zhong B, et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 2008;29:538-550.
63. Gack MU, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007;446:916-920.
64. Friedman CS, et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 2008;9:930-936.
65. Oshiumi H, Matsumoto M, Hatakeyama S, Seya T. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-β induction during the early phase of viral infection. J Biol Chem 2009;284:807-817.
66. Arimoto KI, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci USA 2007;104:7500-7505.
67. Gao D, et al. REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS ONE 2009;4:e5760.
68. Arimoto KI, Konishi H, Shimotohno K. UbcH8 regulates ubiquitin and ISG15 conjugation to RIG-I. Mol Immunol 2008;45:1078-1084.
69. Tang ED, Wang CY. MAVS self-association mediates antiviral innate immune signaling. J Virol 2009;83:3420-8.
70. Onoguchi K, et al. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 2010;6:e1001012.
71. Yasukawa K, et al. Mitofusin 2 inhibits mitochondrial antiviral signaling. Sci Signal 2009;2:ra47.
72. Bowie AG, Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 2008;8:911-922.
73. Komuro A, Bamming D, Horvath CM. Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 2008;43:350-358.